Login to Your Account

Immusoft Applies Computer Science Knowledge to Disease

By Marie Powers
Staff Writer

Friday, August 17, 2012

Although the concept of cell programming isn't new, Immusoft Corp.'s approach represents a new spin on the science.

For a biotech company, Seattle-based Immusoft started with a decidedly different pedigree. With a background in computer sciences rather than chemistry or biology, Matthew Scholz, the company's founder and CEO, conceived an idea to fight disease by modifying information in human immune cells.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription